首页> 外文期刊>Surgical Case Reports >Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report
【24h】

Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report

机译:血小板生成素受体激动剂成功切除特发性血小板减少性紫癜肝内胆管癌:一例

获取原文
获取外文期刊封面目录资料

摘要

Abstract BackgroundPatients with idiopathic thrombocytopenic purpura (ITP) have low platelet counts and an increased risk of complications. Therefore, these patients generally require high-dose immunoglobulin therapy and platelet transfusion. However, thrombopoietin receptor agonists (TPO-RAs) have recently become available for use in the preoperative treatment strategy for intractable ITP. Recent studies have also reported radiofrequency ablation (RFA) or tissue biopsy as perioperative management for thrombocytopenia using TPO-RA. However, no report has described the use of TPO-RA in a case of hepatectomy.Case presentationA 76-year-old man presented with intrahepatic cholangiocarcinoma (IHCC) complicated with ITP. His platelet count was 3.5?×?104/μL. To increase platelet levels prior to surgery, romiplostim was administered subcutaneously (70?μg per week for 3?weeks) and eltrombopag was administered orally (25?mg per day for 23?days), as TPO-RA. His platelet count increased to 14.1?×?104/μL. The patient was successfully and safely treated with left hemi-hepatectomy and TPO-RA as preoperative platelet management.ConclusionsThis case suggests that TPO-RA can be effective, and could serve as a new treatment option in the preoperative management of ITP.
机译:摘要背景患有特发性血小板减少性紫癜(ITP)的患者血小板计数低,并发症风险增加。因此,这些患者通常需要大剂量免疫球蛋白治疗和血小板输注。然而,血小板生成素受体激动剂(TPO-RAs)最近可用于顽固性ITP的术前治疗策略。最近的研究还报道了射频消融(RFA)或组织活检作为使用TPO-RA进行血小板减少症的围手术期处理。然而,尚无报道描述在肝切除术中使用TPO-RA。病例介绍一名76岁的男性患者出现肝内胆管癌(IHCC)并发ITP。他的血小板计数为3.5××104 /μL。为了增加手术前的血小板水平,罗莫司汀经皮下给药(每周70?μg,持续3?周),Eltrombopag口服(每天25?mg,持续23?天),作为TPO-RA。他的血小板计数增加到14.1××104 /μL。该患者已成功并安全地接受了左半肝切除术和TPO-RA作为术前血小板治疗。结论该病例表明TPO-RA是有效的,并可作为ITP术前治疗的新治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号